Do you want to publish a course? Click here

Prevalence of anemia in giardiasis intestinalis in Syrians children

شيوع فقر الدم صند الأطفال السوريين المصابين بالجيارديا المعوية

1277   3   11   0 ( 0 )
 Publication date 2016
  fields Medicine
and research's language is العربية
 Created by Shamra Editor




Ask ChatGPT about the research

In this prospective study done in Syria from mars 2014 to February 2015, Mean serum hemoglobin ,serum hematocrit, serum ferritin, and the ratio of serum iron to total iron-binding capacity were investigated in 100 children aged ( 2-11) years. The study aimed at assessing the extention of anemia in giardiasis intestinalis in Syrians children.

References used
Addiss DG et al. Evaluation of a commerccially available enzyme-linked immunossorbent assay for Giardia lamblia antigen in stool. Journal of clinical microbiology, 1991, 29(6):1137–42
Thompson RCA et al. Genetic variation in Giardia, Kunstler 1882: taxonomic and epidemiological significance. Protozooloogy abstracts, 1990, 14:1–28
Reitmeyer M, Robertson S. Giardiasis. Chief Medical Resident’s Clinical Medicine Conferences 1111–97. Charlottesville, Virginia, University of Virginia, 1997
rate research

Read More

This study included 502 children between 0,5-15 years old. They were all subjected to duodenal biobsy for several reasons, and underwent investigations; Hb, MCV, MCH, MCHC and RDW. The prevalence of celiac disease among anemic children was higher than nonanemic patients (36,04% vs 12,14%). The mean duration of compliance was higher in both anemic children and celiac patients than in comparing groups .The mean levels of Hb,MCV,MCH and MCHC were lower in celiac group, while RDW was higher. Anemia was the most common presentation of celiac disease and it was seen in 77% among celiac children, while failure to thrive was detected in 43% of celiac group. Clinicians should consider celiac disease as a possible cause of anemia in all subjects with unexplained or refractory anemia
This study aims to show the effectiveness of hydroxyl urea in the treatment of severe forms of sickle-cell anemia. The study included 30 patients from patients with sickle cell anemia and who reviewed the Blood clinics in AL- Assad University Hosp ital . We had studied patients treated with hydroxy urea for at least 6 months, where it was compared to blood and clinical variables before and after hydroxy urea treatment. The results showed an improvement in blood and clinical manifestations , and it was noted a significant increase in the level of fetal hemoglobin, and a decrease in the level of hemoglobin and sickle cell after hydroxy urea treatment. hydroxy urea treatment also led to a clear increase in the level of total hemoglobin, and a decrease in the value of total bilirubin. Decrease in the number of the pain episodes that needed hospitalization, and the number of times of blood transfusion after treatment, too.
The number of children with heart diseases in the Syrian society is constantly growing , In view of the importance of oral health and oral manifestations to this group of patients and the difficulties which dentists face in treating them , it is ve ry important to study oral health and the dental caries prevalence. This study seeks to determine the prevalence of dental caries and to evaluate previous dental treatment in children with heart diseases in Damascus hospitals.
Our study aimed to evaluating significance of survivin as a prognostic marker of relapse in children with acute lymphoblastic leukemia. The study included 46 child (30 males, 16 females): 24 child with ALL at 35 day from BFM 95 Protocol and 22 rel apse child with ALL.
we delivered 8,000 IU epoetin three times per week to 30 anemic cancer patients for two months.we measured serum erythropoietin level before the initiation of the treatment.Hemoglobin concentration and other hematological parameters were measured dur ing the treatment. 53% of patients responded to the treatment within 8 weeks. 71% of patients with serum erythropoietin < 100 U/L responded, whereas 27% with values > 100 U/L did.80% of patients with hematological malignancies responded, whereas 39% of patients with solid tumors did .Reticulocyte increment after two weeks in responder patients was higher than non responders.response rate was higher in patients with Hb increment > 0.5 g/dL after 2 weeks ( 83% versus 31% ), and in those with Hb increment > 1 g/dL after 4 weeks ( 93% versus 14% ). response to erythropoietin can be predicted by pretreatment serum erythropoietin level together with early changes in other hematological parameters.

suggested questions

comments
Fetching comments Fetching comments
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا